News and Announcements
RAW Alpha Systematic Fund I – May 2014 Monthly Report
- Published June 10, 2014 4:49PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
The Fund posted a loss of 1.11% in May as profits in Equities were insufficient to offset losses in Grains and Soft Commodities.
The System trimmed positions in Corn and Wheat after those markets declined, but the main driver of performance was Coffee, which posted losses in both the Robusta and Arabica contracts.
Within Equity markets, tilts towards Hong Kong and India led the way, with the bulk of the remaining countries also posting gains. Elsewhere, gains in Fixed Income were able to offset losses in Currencies, while Volatility and Property markets provided gains as well.
The Fund enters June with a diversified mix of investments across all Asset Classes, with slightly less directional risk than the last month.
To read the full report please download the document below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
